COVID-19 Impact on Global Parkinson's Disease Therapeutics Market Size, Status and Forecast 2020-2026

1 Report Overview

• 1.1 Study Scope
• 1.2 Key Market Segments
• 1.3 Players Covered: Ranking by Parkinson's Disease Therapeutics Revenue
• 1.4 Market Analysis by Type
  • 1.4.1 Global Parkinson's Disease Therapeutics Market Size Growth Rate by Type: 2020 VS 2026
  • 1.4.2 Medications Therapeutics
  • 1.4.3 Medical Devices Therapeutics
• 1.5 Market by Application
  • 1.5.1 Global Parkinson's Disease Therapeutics Market Share by Application: 2020 VS 2026
  • 1.5.2 Under 40 Years Old
  • 1.5.3 40-65 Years Old
  • 1.5.4 Above 65 Years Old
• 1.6 Coronavirus Disease 2019 (Covid-19): Parkinson's Disease Therapeutics Industry Impact
  • 1.6.1 How the Covid-19 is Affecting the Parkinson's Disease Therapeutics Industry
    • 1.6.1.1 Parkinson's Disease Therapeutics Business Impact Assessment - Covid-19
    • 1.6.1.2 Supply Chain Challenges
    • 1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
  • 1.6.2 Market Trends and Parkinson's Disease Therapeutics Potential Opportunities in the COVID-19 Landscape
  • 1.6.3 Measures / Proposal against Covid-19
    • 1.6.3.1 Government Measures to Combat Covid-19 Impact
    • 1.6.3.2 Proposal for Parkinson's Disease Therapeutics Players to Combat Covid-19 Impact
• 1.7 Study Objectives
• 1.8 Years Considered

2 Global Growth Trends by Regions

• 2.1 Parkinson's Disease Therapeutics Market Perspective (2015-2026)
• 2.2 Parkinson's Disease Therapeutics Growth Trends by Regions
  • 2.2.1 Parkinson's Disease Therapeutics Market Size by Regions: 2015 VS 2020 VS 2026
  • 2.2.2 Parkinson's Disease Therapeutics Historic Market Share by Regions (2015-2020)
  • 2.2.3 Parkinson's Disease Therapeutics Forecasted Market Size by Regions (2021-2026)
• 2.3 Industry Trends and Growth Strategy
  • 2.3.1 Market Top Trends
  • 2.3.2 Market Drivers
  • 2.3.3 Market Challenges
  • 2.3.4 Porter’s Five Forces Analysis
  • 2.3.5 Parkinson's Disease Therapeutics Market Growth Strategy
  • 2.3.6 Primary Interviews with Key Parkinson's Disease Therapeutics Players (Opinion Leaders)

3 Competition Landscape by Key Players

• 3.1 Global Top Parkinson's Disease Therapeutics Players by Market Size
  • 3.1.1 Global Top Parkinson's Disease Therapeutics Players by Revenue (2015-2020)
  • 3.1.2 Global Parkinson's Disease Therapeutics Revenue Market Share by Players (2015-2020)
  • 3.1.3 Global Parkinson's Disease Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 3.2 Global Parkinson's Disease Therapeutics Market Concentration Ratio
  • 3.2.1 Global Parkinson's Disease Therapeutics Market Concentration Ratio (CR5 and HHI)
  • 3.2.2 Global Top 10 and Top 5 Companies by Parkinson's Disease Therapeutics Revenue in 2019
• 3.3 Parkinson's Disease Therapeutics Key Players Head office and Area Served
• 3.4 Key Players Parkinson's Disease Therapeutics Product Solution and Service
• 3.5 Date of Enter into Parkinson's Disease Therapeutics Market
• 3.6 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type (2015-2026)

• 4.1 Global Parkinson's Disease Therapeutics Historic Market Size by Type (2015-2020)
• 4.2 Global Parkinson's Disease Therapeutics Forecasted Market Size by Type (2021-2026)

5 Parkinson's Disease Therapeutics Breakdown Data by Application (2015-2026)

• 5.1 Global Parkinson's Disease Therapeutics Market Size by Application (2015-2020)
• 5.2 Global Parkinson's Disease Therapeutics Forecasted Market Size by Application (2021-2026)

6 North America

• 6.1 North America Parkinson's Disease Therapeutics Market Size (2015-2020)
• 6.2 Parkinson's Disease Therapeutics Key Players in North America (2019-2020)
• 6.3 North America Parkinson's Disease Therapeutics Market Size by Type (2015-2020)
• 6.4 North America Parkinson's Disease Therapeutics Market Size by Application (2015-2020)

7 Europe

• 7.1 Europe Parkinson's Disease Therapeutics Market Size (2015-2020)
• 7.2 Parkinson's Disease Therapeutics Key Players in Europe (2019-2020)
• 7.3 Europe Parkinson's Disease Therapeutics Market Size by Type (2015-2020)
• 7.4 Europe Parkinson's Disease Therapeutics Market Size by Application (2015-2020)

8 China

• 8.1 China Parkinson's Disease Therapeutics Market Size (2015-2020)
• 8.2 Parkinson's Disease Therapeutics Key Players in China (2019-2020)
• 8.3 China Parkinson's Disease Therapeutics Market Size by Type (2015-2020)
• 8.4 China Parkinson's Disease Therapeutics Market Size by Application (2015-2020)

9 Japan

• 9.1 Japan Parkinson's Disease Therapeutics Market Size (2015-2020)
• 9.2 Parkinson's Disease Therapeutics Key Players in Japan (2019-2020)
• 9.3 Japan Parkinson's Disease Therapeutics Market Size by Type (2015-2020)
• 9.4 Japan Parkinson's Disease Therapeutics Market Size by Application (2015-2020)

10 Southeast Asia

• 10.1 Southeast Asia Parkinson's Disease Therapeutics Market Size (2015-2020)
• 10.2 Parkinson's Disease Therapeutics Key Players in Southeast Asia (2019-2020)
• 10.3 Southeast Asia Parkinson's Disease Therapeutics Market Size by Type (2015-2020)
• 10.4 Southeast Asia Parkinson's Disease Therapeutics Market Size by Application (2015-2020)

11 India

• 11.1 India Parkinson's Disease Therapeutics Market Size (2015-2020)
• 11.2 Parkinson's Disease Therapeutics Key Players in India (2019-2020)
• 11.3 India Parkinson's Disease Therapeutics Market Size by Type (2015-2020)
• 11.4 India Parkinson's Disease Therapeutics Market Size by Application (2015-2020)

12 Central & South America

• 12.1 Central & South America Parkinson's Disease Therapeutics Market Size (2015-2020)
• 12.2 Parkinson's Disease Therapeutics Key Players in Central & South America (2019-2020)
• 12.3 Central & South America Parkinson's Disease Therapeutics Market Size by Type (2015-2020)
• 12.4 Central & South America Parkinson's Disease Therapeutics Market Size by Application (2015-2020)

13 Key Players Profiles

• 13.1 GSK
  • 13.1.1 GSK Company Details
  • 13.1.2 GSK Business Overview and Its Total Revenue
  • 13.1.3 GSK Parkinson's Disease Therapeutics Introduction
  • 13.1.4 GSK Revenue in Parkinson's Disease Therapeutics Business (2015-2020))
  • 13.1.5 GSK Recent Development
• 13.2 Novartis
  • 13.2.1 Novartis Company Details
  • 13.2.2 Novartis Business Overview and Its Total Revenue
  • 13.2.3 Novartis Parkinson's Disease Therapeutics Introduction
  • 13.2.4 Novartis Revenue in Parkinson's Disease Therapeutics Business (2015-2020)
  • 13.2.5 Novartis Recent Development
• 13.3 Boehringer Ingelheim
  • 13.3.1 Boehringer Ingelheim Company Details
  • 13.3.2 Boehringer Ingelheim Business Overview and Its Total Revenue
  • 13.3.3 Boehringer Ingelheim Parkinson's Disease Therapeutics Introduction
  • 13.3.4 Boehringer Ingelheim Revenue in Parkinson's Disease Therapeutics Business (2015-2020)
  • 13.3.5 Boehringer Ingelheim Recent Development
• 13.4 Teva Pharmaceutical
  • 13.4.1 Teva Pharmaceutical Company Details
  • 13.4.2 Teva Pharmaceutical Business Overview and Its Total Revenue
  • 13.4.3 Teva Pharmaceutical Parkinson's Disease Therapeutics Introduction
  • 13.4.4 Teva Pharmaceutical Revenue in Parkinson's Disease Therapeutics Business (2015-2020)
  • 13.4.5 Teva Pharmaceutical Recent Development
• 13.5 Abbvie
  • 13.5.1 Abbvie Company Details
  • 13.5.2 Abbvie Business Overview and Its Total Revenue
  • 13.5.3 Abbvie Parkinson's Disease Therapeutics Introduction
  • 13.5.4 Abbvie Revenue in Parkinson's Disease Therapeutics Business (2015-2020)
  • 13.5.5 Abbvie Recent Development
• 13.6 Merck
  • 13.6.1 Merck Company Details
  • 13.6.2 Merck Business Overview and Its Total Revenue
  • 13.6.3 Merck Parkinson's Disease Therapeutics Introduction
  • 13.6.4 Merck Revenue in Parkinson's Disease Therapeutics Business (2015-2020)
  • 13.6.5 Merck Recent Development
• 13.7 Akorn
  • 13.7.1 Akorn Company Details
  • 13.7.2 Akorn Business Overview and Its Total Revenue
  • 13.7.3 Akorn Parkinson's Disease Therapeutics Introduction
  • 13.7.4 Akorn Revenue in Parkinson's Disease Therapeutics Business (2015-2020)
  • 13.7.5 Akorn Recent Development
• 13.8 Kyowa Hakko Kirin Pharma
  • 13.8.1 Kyowa Hakko Kirin Pharma Company Details
  • 13.8.2 Kyowa Hakko Kirin Pharma Business Overview and Its Total Revenue
  • 13.8.3 Kyowa Hakko Kirin Pharma Parkinson's Disease Therapeutics Introduction
  • 13.8.4 Kyowa Hakko Kirin Pharma Revenue in Parkinson's Disease Therapeutics Business (2015-2020)
  • 13.8.5 Kyowa Hakko Kirin Pharma Recent Development
• 13.9 Astellas Pharma
  • 13.9.1 Astellas Pharma Company Details
  • 13.9.2 Astellas Pharma Business Overview and Its Total Revenue
  • 13.9.3 Astellas Pharma Parkinson's Disease Therapeutics Introduction
  • 13.9.4 Astellas Pharma Revenue in Parkinson's Disease Therapeutics Business (2015-2020)
  • 13.9.5 Astellas Pharma Recent Development
• 13.10 Desitin Arzneimittel
  • 13.10.1 Desitin Arzneimittel Company Details
  • 13.10.2 Desitin Arzneimittel Business Overview and Its Total Revenue
  • 13.10.3 Desitin Arzneimittel Parkinson's Disease Therapeutics Introduction
  • 13.10.4 Desitin Arzneimittel Revenue in Parkinson's Disease Therapeutics Business (2015-2020)
  • 13.10.5 Desitin Arzneimittel Recent Development
• 13.11 Endo Pharmaceuticals
  • 10.11.1 Endo Pharmaceuticals Company Details
  • 10.11.2 Endo Pharmaceuticals Business Overview and Its Total Revenue
  • 10.11.3 Endo Pharmaceuticals Parkinson's Disease Therapeutics Introduction
  • 10.11.4 Endo Pharmaceuticals Revenue in Parkinson's Disease Therapeutics Business (2015-2020)
  • 10.11.5 Endo Pharmaceuticals Recent Development
• 13.12 F.Hoffmann-La Roche
  • 10.12.1 F.Hoffmann-La Roche Company Details
  • 10.12.2 F.Hoffmann-La Roche Business Overview and Its Total Revenue
  • 10.12.3 F.Hoffmann-La Roche Parkinson's Disease Therapeutics Introduction
  • 10.12.4 F.Hoffmann-La Roche Revenue in Parkinson's Disease Therapeutics Business (2015-2020)
  • 10.12.5 F.Hoffmann-La Roche Recent Development
• 13.13 H.Lundbeck
  • 10.13.1 H.Lundbeck Company Details
  • 10.13.2 H.Lundbeck Business Overview and Its Total Revenue
  • 10.13.3 H.Lundbeck Parkinson's Disease Therapeutics Introduction
  • 10.13.4 H.Lundbeck Revenue in Parkinson's Disease Therapeutics Business (2015-2020)
  • 10.13.5 H.Lundbeck Recent Development
• 13.14 Valeant
  • 10.14.1 Valeant Company Details
  • 10.14.2 Valeant Business Overview and Its Total Revenue
  • 10.14.3 Valeant Parkinson's Disease Therapeutics Introduction
  • 10.14.4 Valeant Revenue in Parkinson's Disease Therapeutics Business (2015-2020)
  • 10.14.5 Valeant Recent Development
• 13.15 Apokyn
  • 10.15.1 Apokyn Company Details
  • 10.15.2 Apokyn Business Overview and Its Total Revenue
  • 10.15.3 Apokyn Parkinson's Disease Therapeutics Introduction
  • 10.15.4 Apokyn Revenue in Parkinson's Disease Therapeutics Business (2015-2020)
  • 10.15.5 Apokyn Recent Development
• 13.16 Orion
  • 10.16.1 Orion Company Details
  • 10.16.2 Orion Business Overview and Its Total Revenue
  • 10.16.3 Orion Parkinson's Disease Therapeutics Introduction
  • 10.16.4 Orion Revenue in Parkinson's Disease Therapeutics Business (2015-2020)
  • 10.16.5 Orion Recent Development
• 13.17 Stada Arzneimittel
  • 10.17.1 Stada Arzneimittel Company Details
  • 10.17.2 Stada Arzneimittel Business Overview and Its Total Revenue
  • 10.17.3 Stada Arzneimittel Parkinson's Disease Therapeutics Introduction
  • 10.17.4 Stada Arzneimittel Revenue in Parkinson's Disease Therapeutics Business (2015-2020)
  • 10.17.5 Stada Arzneimittel Recent Development
• 13.18 US WorldMeds
  • 10.18.1 US WorldMeds Company Details
  • 10.18.2 US WorldMeds Business Overview and Its Total Revenue
  • 10.18.3 US WorldMeds Parkinson's Disease Therapeutics Introduction
  • 10.18.4 US WorldMeds Revenue in Parkinson's Disease Therapeutics Business (2015-2020)
  • 10.18.5 US WorldMeds Recent Development
• 13.19 Bausch Health
  • 10.19.1 Bausch Health Company Details
  • 10.19.2 Bausch Health Business Overview and Its Total Revenue
  • 10.19.3 Bausch Health Parkinson's Disease Therapeutics Introduction
  • 10.19.4 Bausch Health Revenue in Parkinson's Disease Therapeutics Business (2015-2020)
  • 10.19.5 Bausch Health Recent Development

14 Analyst's Viewpoints/Conclusions

15 Appendix

• 15.1 Research Methodology
  • 15.1.1 Methodology/Research Approach
  • 15.1.2 Data Source
• 15.2 Disclaimer